Clinical Trial Update: An Open Trial of Cysteamine Treatment in Schizophrenia [NA]

View source ↗

Summary

An open-label clinical trial of cysteamine for schizophrenia (also studied for schizoaffective disorder) was terminated, with results posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizoaffective Disorder
• Schizophrenia

Drugs mentioned

• Cysteamine (cysteamine)

Snippet

Sponsor: Augusta University | Conditions: Schizophrenia, Schizoaffective | NA | Status: TERMINATED | Results posted: 2014-11-20